You are here

  • Home
  • Archive
  • Volume 82, Issue 4
  • Response to: ‘Correspondence on ‘Anti-inflammatory therapy for COVID-19 infection: the case for colchicine’’ by Perricone et al

Citation Tools

Article menu
Download PDFPDF
Correspondence response
Response to: ‘Correspondence on ‘Anti-inflammatory therapy for COVID-19 infection: the case for colchicine’’ by Perricone et al

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Shah B, Reyes AZ, Hu KA, et al
Response to: ‘Correspondence on ‘Anti-inflammatory therapy for COVID-19 infection: the case for colchicine’’ by Perricone et al
Annals of the Rheumatic Diseases 2023;82:e82.